Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
You’re invited to join our “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now. MGFA is offering this online webinar program series to anyone interested in learning more about this ongoing MG research in investigative therapies. We hope you’ll register for the latest update.
Up Next:
Targeted Treatment for Generalized Myasthenia Gravis
Thursday, May 16, 4:30 PM EDT / 1:30 PM PDT
Presented by: Christyn Edmundson, MD
Register
Christyn Edmundson, MD, will share educational information about a targeted treatment for generalized myasthenia gravis. The webinar will include key details about an FDA-approved treatment for adults with gMG who are anti-AChR (acetylcholine receptor) antibody positive, including how it works, what patients and caregivers can expect with this treatment, and helpful points for how to talk with a doctor about gMG symptoms and treatment. Dr. Edmundson practices as the Swedish Neuroscience Institute as the director of neuromuscular medicine.
This webinar is sponsored by UCB.